115 related articles for article (PubMed ID: 9828833)
1. Antisense WT1 transcription parallels sense mRNA and protein expression in fetal kidney and can elevate protein levels in vitro.
Moorwood K; Charles AK; Salpekar A; Wallace JI; Brown KW; Malik K
J Pathol; 1998 Aug; 185(4):352-9. PubMed ID: 9828833
[TBL] [Abstract][Full Text] [Related]
2. Expression of WT1 protein in fetal kidneys and Wilms tumors.
Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
[TBL] [Abstract][Full Text] [Related]
3. Identification of an antisense WT1 promoter in intron 1: implications for WT1 gene regulation.
Malik KT; Wallace JI; Ivins SM; Brown KW
Oncogene; 1995 Oct; 11(8):1589-95. PubMed ID: 7478583
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific regulation of the WT1 locus.
Hewitt JA; Kessler PM; Campbell CE; Williams BR
Med Pediatr Oncol; 1996 Nov; 27(5):456-61. PubMed ID: 8827074
[TBL] [Abstract][Full Text] [Related]
5. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.
Algar EM; Khromykh T; Smith SI; Blackburn DM; Bryson GJ; Smith PJ
Oncogene; 1996 Mar; 12(5):1005-14. PubMed ID: 8649791
[TBL] [Abstract][Full Text] [Related]
6. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
Iben S; Royer-Pokora B
Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
[TBL] [Abstract][Full Text] [Related]
7. Analysis of WT1 target gene expression in stably transfected cell lines.
Thäte C; Englert C; Gessler M
Oncogene; 1998 Sep; 17(10):1287-94. PubMed ID: 9771972
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
9. Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1.
Li RS; Law GL; Seifert RA; Romaniuk PJ; Morris DR
Exp Cell Res; 1999 Feb; 247(1):257-66. PubMed ID: 10047468
[TBL] [Abstract][Full Text] [Related]
10. Wilms' tumor suppressor gene (WT1) as a target gene of SRY function in a mouse ES cell line transfected with SRY.
Toyooka Y; Tanaka SS; Hirota O; Tanaka S; Takagi N; Yamanouchi K; Tojo H; Tachi C
Int J Dev Biol; 1998 Nov; 42(8):1143-51. PubMed ID: 9879712
[TBL] [Abstract][Full Text] [Related]
11. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.
Rae FK; Martinez G; Gillinder KR; Smith A; Shooter G; Forrest AR; Grimmond SM; Little MH
Oncogene; 2004 Apr; 23(17):3067-79. PubMed ID: 15021918
[TBL] [Abstract][Full Text] [Related]
12. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
13. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
14. Hox11 is required to maintain normal Wt1 mRNA levels in the developing spleen.
Koehler K; Franz T; Dear TN
Dev Dyn; 2000 May; 218(1):201-6. PubMed ID: 10822272
[TBL] [Abstract][Full Text] [Related]
15. Cloning of novel Wilms tumor gene (WT1) cDNAs; evidence for antisense transcription of WT1.
Eccles MR; Grubb G; Ogawa O; Szeto J; Reeve AE
Oncogene; 1994 Jul; 9(7):2059-63. PubMed ID: 8208551
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the Wilms' tumour suppressor (WT1) gene by an antisense RNA: a link with genomic imprinting?
Ward A; Dutton JR
J Pathol; 1998 Aug; 185(4):342-4. PubMed ID: 9828831
[TBL] [Abstract][Full Text] [Related]
17. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.
Mrowka C; Schedl A
J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S106-15. PubMed ID: 11065340
[TBL] [Abstract][Full Text] [Related]
19. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
20. Sense and antisense Foxl2 transcripts in mouse.
Cocquet J; Pannetier M; Fellous M; Veitia RA
Genomics; 2005 May; 85(5):531-41. PubMed ID: 15820304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
